More US mass tort litigation is to be expected. This is what the predictions by Praedicat show. Today, opioid-related claims are up on the agenda with a potential bill of up to USD 864 billion. But there is likely more to come: from sugar to bisphenol A substitutes and a whole range of other chemicals and ingredients. Praedicat also shows that there is meanwhile a huge gap in coverage of insurable risks.
We will discuss the mechanics of US product liability litigation at our Casualty Day on 10 October in Dusseldorf. Find out more here.

/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2025-11-28-09-26-35-845-69296acb26437b7f7f1bf7c7.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2025-11-27-13-53-38-044-692857e25a6bd6a9110e449e.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2025-11-19-08-43-46-615-691d834211052ef2a4d9e5f0.jpg)